General contact information for trials in Manitoba:
- cancercare.mb.ca/Treatments/clinical-trials
- Dr. Leonard Minuk, Director of Clinical Trials, CancerCare Manitoba (904-787-2497)
NO LONGER ACTIVE location in Manitoba:
ID Number: NCT01924819
Links:
Description: This study is trying to understand the best way to treat patients with resectable gastric cancer before their surgery. The researchers want to see if chemotherapy with radiation (chemoradiotherapy) is more helpful than just chemotherapy before surgery. There will be two groups compared in this experiment:
All patients in this study will be having a gastrectomy and a D1 lymphadenectomy. Then, all patients will have chemotherapy after surgery. The researchers will be looking at overall survival in the two groups over time. The estimated end date for the study is December, 2020.
Intervention:
Can I consider participating?
Recruiting location in Manitoba:
ID Number: NCT02935634
Links:
Description: This is a Phase III pilot trial. The participants in this study will be patients with Gastroesophageal Junction adenocarcinoma. The researchers want to know if perioperative chemotherapy or preoperative chemoradiotherapy is more helpful. This is a pilot study, which means that it is quite small and the researchers are trying to figure out if it is feasible to conduct a larger trial to answer their question with more data. They will compare the survival of two groups to try and find a better treatment for Gastroesophageal Junction cancer:
Intervention:
Can I consider participating?
NO LONGER Recruiting – active locations in Manitoba:
ID Number: NCT03797326
Links:
Description:This study is looking at the safety and effectiveness of combination therapy with pembrolizumab (MK-3475) and lenvatinib (E7080/Mk-7902).
Group A: Pembrolizumab and lenvatinib
Intervention: Pembrolizumab is an immunotherapy drug that will help immune system cells to attack and get rid of cancer cells. Lenvatinib is a targeted chemotherapy drug that is a tyrosine kinase inhibitor. It slows down or stops the growth of cancer cells.
Can I consider participating?